SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 21 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DLD Asset Management, LP | 10,370,000 | $18,432,675 | 1.98% |
| Worth Venture Partners, LLC | 1,431,000 | $2,536,677 | 1.50% |
| CSS LLC/IL | 8,197,000 | $14,535,142 | 0.95% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,198,000 | $9,252,647 | 0.20% |
| Warberg Asset Management LLC | 517,000 | $911,580 | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 3,889,000 | $6,893,877 | 0.16% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,000,000 | $1,765,625 | 0.05% |
| Point72 Asset Management, L.P. | 9,007,000 | $15,925,009 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,082,000 | $8,984,976 | 0.04% |
| D. E. Shaw & Co., Inc. | 11,089,000 | $19,645,113 | 0.02% |
| OFI INVEST ASSET MANAGEMENT | 300 | $534,204 | 0.02% |
| Leucadia National | 144,000 | $255,678 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5,632,000 | $9,943,297 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| AMERICAN CENTURY COMPANIES INC | 75,000 | $132,600 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,000 | $1,788 | 0.00% |
| CITIGROUP INC | 279,000 | $492,575 | 0.00% |
| MORGAN STANLEY | 2,000 | $3,520 | 0.00% |
| FMR LLC | 1,495,000 | $2,639,423 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 2,000 | $3,532 | 0.00% |
This page lists SAREPTA THERAPEUTICS INC's shareholders in Q3 2023. To view SAREPTA THERAPEUTICS INC's shareholder history, click here.